Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Thoracic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 24Wilms Tumor 9Neuroblastoma 7Lymphoma, Non-Hodgkin 7Hepatoblastoma 7Glioma 7Rhabdoid Tumor 6Osteosarcoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Medulloblastoma 6Histiocytosis, Langerhans-Cell 6Ependymoma 6Sarcoma 5Rhabdomyosarcoma 5Central Nervous System Neoplasms 5Sarcoma, Ewing 4Lung Neoplasms 4Carcinoma, Renal Cell 4Melanoma 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Lymphoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2

Interventions

Radiosurgery 9Magnetic Resonance Spectroscopy 6pembrolizumab 4Radiotherapy 4Nivolumab 4Fluorodeoxyglucose F18 4cabozantinib 3Specimen Handling 3Paclitaxel 3Melphalan 3Ipilimumab 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Busulfan 3lenvatinib 2entrectinib 2cediranib 2Thiotepa 2Sunitinib 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Injections 2Ifosfamide 2FAPI-46 2Etoposide 2Carboplatin 2Bone Marrow Transplantation 2Bevacizumab 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × X-Rays × Genitourinary × Clear all
NCT00756639 2025-12-17

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled
CNSGenitourinary

Adenocarcinoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡